mastering cgt process development: overcoming challenges on the path to commercialization [webinar]
Published 3 months ago • 165 plays • Length 56:26Download video MP4
Download video MP3
Similar videos
-
![non-viral t cell engineering for clinical manufacturing [webinar]](https://i.ytimg.com/vi/DO1X0-WtOqU/mqdefault.jpg)
57:57
non-viral t cell engineering for clinical manufacturing [webinar]
-
30:22
potential challenges throughout the development process
-
![engineered cell therapies – potential and development of non-viral methods [webinar]](https://i.ytimg.com/vi/2NLHWpPTHpk/mqdefault.jpg)
39:21
engineered cell therapies – potential and development of non-viral methods [webinar]
-
![how to successfully validate flow cytometry assays for cell and gene therapies [webinar]](https://i.ytimg.com/vi/MgKQL54pb38/mqdefault.jpg)
32:32
how to successfully validate flow cytometry assays for cell and gene therapies [webinar]
-
59:45
webinar: manufacturing challenges facing cell and gene therapy
-
1:54
the game changer in cgt cell product formulation and final fill
-
![automating hsc gene engineering in a functionally closed system [webinar]](https://i.ytimg.com/vi/Un5SwKv8N0E/mqdefault.jpg)
22:50
automating hsc gene engineering in a functionally closed system [webinar]
-
25:28
process development and control strategy for an efficient large scale manufacturing process
-
47:40
panel discussion on peptides characterization and impurities
-
57:19
a cgmp compatible, non-viral car t cell manufacturing process
-
55:43
critical pathfinding: how cdmo partnership can accelerate clinical results in cell therapy
-
22:35
strategic development of characterization and quality control programs for therapeutic peptides
-
![improve your clinical-grade treg manufacturing [webinar]](https://i.ytimg.com/vi/OVX50WhYlZY/mqdefault.jpg)
38:51
improve your clinical-grade treg manufacturing [webinar]
-
53:33
early process development options and speed to clinic webinar
-
1:43
are you ready to level up in cell and gene therapy?
-
1:13:24
manufacturing strategies for biosimilars: a case of continuous capture
-
7:59
panel discussion emerging bio therapies and their manufacturing challenges